Clinical Trial Detail

NCT ID NCT02575807
Title Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian, or Peritoneal Cancer
Recruitment Terminated
Gender female
Phase Phase Ib/II
Variant Requirements no
Sponsors Aduro Biotech, Inc.
Indications

peritoneum cancer

fallopian tube cancer

ovarian cancer

Therapies

Epacadostat

CRS-207

Age Groups: adult

No variant requirements are available.